These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Ecstacy: a review of MDMA and MDA.
    Author: Climko RP, Roehrich H, Sweeney DR, Al-Razi J.
    Journal: Int J Psychiatry Med; ; 16(4):359-72. PubMed ID: 2881902.
    Abstract:
    The Drug Enforcement Administration classified the drug methylenedioxymethamphetamine, MDMA, also known as Ecstacy, as a Schedule I controlled substance on July 1, 1985. The controversy surrounding the classification of MDMA is related to the question of its efficacy as an adjunct to psychotherapy and the larger issue of how to regulate the production and use of designer drugs. The authors review the literature on MDMA and its predecessor, MDA, a substance that differs from MDMA by one methyl group.
    [Abstract] [Full Text] [Related] [New Search]